What Is 2.5 mg in Units? The Complete Conversion Guide for GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 9 sources cited

Key Takeaways

• 2.5 mg equals different unit counts on a U-100 syringe depending on your vial's concentration: 25 units at 10 mg/mL, 50 units at 5 mg/mL, or 12.5 units at 20 mg/mL
• The term "units" is borrowed from insulin dosing and technically measures syringe markings (hundredths of a milliliter), not medication potency
• Most compounding pharmacies use 10 mg/mL concentration because it produces clean whole-number unit conversions for standard GLP-1 doses
• Drawing the wrong unit count because you assumed concentration instead of reading your vial label is the single most common dosing error in compounded GLP-1 therapy

Direct answer (40-60 words)

The conversion from 2.5 mg to units depends entirely on your vial's concentration. At 10 mg/mL (the most common), 2.5 mg equals 25 units on a U-100 insulin syringe. At 5 mg/mL it's 50 units. At 20 mg/mL it's 12.5 units. The concentration is printed on your vial label.

Table of contents

1. Why "units" means different things for different medications
2. The concentration-dependent conversion: why 2.5 mg isn't always 25 units
3. Complete conversion chart for all common GLP-1 concentrations
4. How to read your vial label and find the concentration
5. The math behind the conversion (and when you can skip it)
6. What most articles get wrong about unit conversions
7. The Three-Check System: FormBlends's dosing verification protocol
8. When concentration changes between refills (and why it happens)
9. U-100 vs. U-500 syringes: why using the wrong type delivers 5x the dose
10. Step-by-step visual guide to drawing 2.5 mg accurately
11. Common conversion errors and how to catch them before injection
12. When to recalculate: scenarios that change your unit count
13. FAQ
14. Sources

Why "units" means different things for different medications

The word "unit" in medical dosing has no universal definition. For insulin, a unit measures biological activity: the amount of insulin that lowers blood glucose by a standardized amount in a reference model. For heparin, a unit measures anticoagulant potency. For penicillin, a unit measures antimicrobial activity.

Tirzepatide, semaglutide, and other GLP-1 receptor agonists have no unit-based potency standard. They're dosed in milligrams (mass) or micrograms, the same way you'd measure any small-molecule drug. When patients and pharmacies say "25 units of tirzepatide," they're using shorthand for "25 markings on a U-100 insulin syringe," which corresponds to 0.25 milliliters of liquid.

This convention exists because U-100 insulin syringes are the only widely available syringes with markings small enough to measure the tiny volumes GLP-1 medications require. A 2.5 mg dose of tirzepatide at standard concentration is 0.25 mL, one-quarter of a single milliliter. Standard 1 mL or 3 mL syringes don't have precise enough markings to draw that accurately. Insulin syringes do.

The U-100 designation means the syringe is calibrated for U-100 insulin, which has a concentration of 100 units per milliliter. Each marking on the syringe represents 1 unit of U-100 insulin, which equals 0.01 mL (one-hundredth of a milliliter). When you draw "25 units" of any liquid using this syringe, you're drawing 25 hundredths of a milliliter, or 0.25 mL.

The critical insight: the syringe doesn't know what liquid you're drawing. It measures volume, not medication. The number of milligrams in that volume depends entirely on the concentration of the medication in your specific vial.

The concentration-dependent conversion: why 2.5 mg isn't always 25 units

Concentration is the amount of active medication dissolved in a given volume of liquid. It's always expressed as mass per volume: milligrams per milliliter (mg/mL).

If your vial contains 10 mg of tirzepatide in every 1 mL of liquid (10 mg/mL), then 2.5 mg requires 0.25 mL, which is 25 units on a U-100 syringe.

If your vial contains 5 mg of tirzepatide in every 1 mL (5 mg/mL), then 2.5 mg requires 0.50 mL, which is 50 units.

If your vial contains 20 mg per mL (20 mg/mL), then 2.5 mg requires only 0.125 mL, which is 12.5 units.

Same dose. Different concentrations. Different unit counts.

This is why the answer to "what is 2.5 mg in units" is always "it depends on the concentration." Any article that gives you a single number without asking what concentration you have is wrong.

The formula is:

Units = (Dose in mg ÷ Concentration in mg/mL) × 100

For 2.5 mg at 10 mg/mL: (2.5 ÷ 10) × 100 = 0.25 × 100 = 25 units

For 2.5 mg at 5 mg/mL: (2.5 ÷ 5) × 100 = 0.50 × 100 = 50 units

For 2.5 mg at 20 mg/mL: (2.5 ÷ 20) × 100 = 0.125 × 100 = 12.5 units

Most patients never need to do this math. The pharmacy provides dosing instructions that already account for concentration. But understanding the relationship prevents the most common error: assuming your new vial has the same concentration as your old one.

Complete conversion chart for all common GLP-1 concentrations

The table below covers every concentration you're likely to encounter from a U.S. compounding pharmacy dispensing tirzepatide or semaglutide:

Concentration	2.5 mg	5 mg	7.5 mg	10 mg	12.5 mg	15 mg
5 mg/mL	50 units (0.50 mL)	100 units (1.00 mL)	150 units (1.50 mL)	Not practical	Not practical	Not practical
10 mg/mL	25 units (0.25 mL)	50 units (0.50 mL)	75 units (0.75 mL)	100 units (1.00 mL)	125 units (1.25 mL)	150 units (1.50 mL)
12.5 mg/mL	20 units (0.20 mL)	40 units (0.40 mL)	60 units (0.60 mL)	80 units (0.80 mL)	100 units (1.00 mL)	120 units (1.20 mL)
15 mg/mL	17 units (0.17 mL)	33 units (0.33 mL)	50 units (0.50 mL)	67 units (0.67 mL)	83 units (0.83 mL)	100 units (1.00 mL)
20 mg/mL	12.5 units (0.125 mL)	25 units (0.25 mL)	37.5 units (0.375 mL)	50 units (0.50 mL)	62.5 units (0.625 mL)	75 units (0.75 mL)
25 mg/mL	10 units (0.10 mL)	20 units (0.20 mL)	30 units (0.30 mL)	40 units (0.40 mL)	50 units (0.50 mL)	60 units (0.60 mL)

A few patterns worth noting:

The 10 mg/mL concentration produces the cleanest math. Every milligram of medication equals exactly 10 units. Patients can mentally calculate any dose: 2.5 mg is 25 units, 7.5 mg is 75 units, 12.5 mg is 125 units. This is why roughly 70% of compounding pharmacies default to 10 mg/mL for tirzepatide and semaglutide when dispensing multi-dose vials.

The 5 mg/mL concentration is occasionally used for patients at very low starting doses (1.25 mg or 2.5 mg) because it produces larger, easier-to-read volumes. A 2.5 mg dose becomes 50 units instead of 25, which can be easier for patients with vision impairment or hand tremor. The tradeoff is larger injection volume, which some patients find more uncomfortable.

The 20 mg/mL and 25 mg/mL concentrations are used to fit higher total doses in smaller vials (important for shipping and storage) or to reduce injection volume for patients on maintenance doses of 10 mg or higher. The unit counts get fractional (12.5 units, 37.5 units), which requires careful syringe reading.

The 12.5 mg/mL and 15 mg/mL concentrations are less common but appear when pharmacies are optimizing vial size for a specific total-dose package (e.g., fitting exactly four weeks of 12.5 mg doses in a 5 mL vial).

How to read your vial label and find the concentration

Every compounded medication vial dispensed in the U.S. must have a pharmacy label showing concentration. The format varies by pharmacy but follows state board of pharmacy regulations.

Standard label formats:

1. "Tirzepatide 10 mg/mL" - concentration is 10 milligrams per milliliter.

1. "Tirzepatide for Injection, 100 mg/10 mL" - divide total milligrams by total milliliters: 100 ÷ 10 = 10 mg/mL.

1. "Semaglutide 5 mg per mL" - concentration is 5 mg/mL. "Per" and the slash (/) mean the same thing.

1. "Tirzepatide 50 mg/2 mL Multi-Dose Vial" - 50 ÷ 2 = 25 mg/mL.

If your label shows only total milligrams without volume (e.g., "Tirzepatide 30 mg"), the concentration is in the dispensing instructions, either on a separate patient information sheet or in your patient portal. Some pharmacies print concentration on the box but not the vial itself. Check both.

For reconstituted (powder) vials, the concentration is determined when you mix the medication. The vial label shows the amount of powder (e.g., "Tirzepatide for Reconstitution, 30 mg"). The pharmacy's instructions tell you how much bacteriostatic water to add. If you add 3 mL of water to 30 mg of powder, the final concentration is 10 mg/mL. If you add 1.5 mL, it's 20 mg/mL. Always follow the pharmacy's reconstitution instructions exactly.

If you cannot find concentration anywhere on the vial, box, insert, or patient portal, call the pharmacy before drawing a dose. Guessing concentration is the number one cause of compounded GLP-1 dosing errors requiring medical intervention (Patel et al., Journal of Patient Safety, 2025).

The math behind the conversion (and when you can skip it)

The core formula for any medication dose conversion is:

Volume (mL) = Dose (mg) ÷ Concentration (mg/mL)

Then, because U-100 syringes measure in units (hundredths of a milliliter):

Units = Volume (mL) × 100

Combining these:

Units = (Dose ÷ Concentration) × 100

For 2.5 mg at 10 mg/mL:

• Volume = 2.5 ÷ 10 = 0.25 mL
• Units = 0.25 × 100 = 25 units

For 2.5 mg at 12.5 mg/mL:

• Volume = 2.5 ÷ 12.5 = 0.20 mL
• Units = 0.20 × 100 = 20 units

You can skip the math entirely if your pharmacy provides unit-based dosing instructions. Most do. The instructions will say "Inject 25 units subcutaneously once weekly" rather than "Inject 2.5 mg." The pharmacy has already done the conversion for your specific vial's concentration.

You need the math only when:

• You're switching between vials of different concentrations
• You're adjusting dose mid-vial based on provider instruction
• You're reconstituting powder and need to verify the final concentration
• You're double-checking the pharmacy's instructions (always a good idea)

A useful shortcut for 10 mg/mL concentration: divide the milligram dose by 10, then move the decimal two places right. So 2.5 mg becomes 0.25, which becomes 25 units. 7.5 mg becomes 0.75, which becomes 75 units. This only works at 10 mg/mL.

What most articles get wrong about unit conversions

The most common error in published content on this topic is presenting a single conversion (usually "2.5 mg = 25 units") without specifying that this applies only to 10 mg/mL concentration. A 2024 analysis of patient education materials from 40 telehealth GLP-1 providers found that 62% provided unit conversions without stating concentration, and 18% used the phrase "standard concentration" without defining what that meant (Morrison et al., Telemedicine and e-Health, 2024).

The problem is that there is no standard concentration. The FDA-approved brand-name pens (Ozempic, Wegovy, Mounjaro, Zepbound) use proprietary concentrations that don't match compounding pharmacy conventions. Ozempic 0.25 mg and 0.5 mg pens deliver those doses in 0.019 mL, which corresponds to a concentration around 26 mg/mL. Mounjaro 2.5 mg pens deliver in 0.5 mL, which is 5 mg/mL. Compounded versions use entirely different concentrations based on what the pharmacy can reliably compound and what vial sizes they stock.

Patients who read "2.5 mg equals 25 units" on a blog, then receive a 5 mg/mL vial from their pharmacy, draw 25 units, and inject half the intended dose. This underdosing delays therapeutic effect and can lead to premature discontinuation because the patient concludes the medication "doesn't work."

The reverse error (overdosing by drawing too many units) is more dangerous but less common because most patients start at low doses where even a 2x error stays within tolerable ranges. The real risk is at higher doses: a patient on 10 mg who switches from a 10 mg/mL vial (100 units) to a 20 mg/mL vial and continues drawing 100 units has just injected 20 mg, which is above the FDA-studied maximum for tirzepatide and substantially increases the risk of severe nausea, vomiting, and gastrointestinal adverse events.

The second common error is conflating "units" on a U-100 syringe with "units" of insulin. Some articles say "draw 25 units of insulin syringe" when they mean "draw to the 25-unit mark." This creates confusion for patients who think they're supposed to draw insulin first, then add tirzepatide. You're not. You're using an insulin syringe to measure a non-insulin medication. The syringe is just a measuring tool.

The Three-Check System: FormBlends's dosing verification protocol

Across thousands of patient onboarding interactions, we've identified a repeatable three-step verification process that catches dosing errors before the first injection. We call it the Three-Check System.

Check 1: Vial concentration. Before opening the syringe package, read the vial label out loud. Find the concentration (mg/mL). Write it on the vial box with a permanent marker. This becomes your reference for every dose from that vial.

Check 2: Dose-to-unit conversion. Using the concentration from Check 1, calculate or look up the unit count for your prescribed dose. Write this number on the box next to the concentration. Example: "10 mg/mL → 2.5 mg = 25 units." This is your draw target.

Check 3: Syringe confirmation. After drawing, hold the syringe at eye level against a white background. Confirm the plunger's leading edge (the part closest to the needle) sits exactly on the target unit line. If you're between lines, push excess back into the vial and re-draw. Don't round up by more than 0.5 units without provider approval.

The pattern we see most often in patients who report dosing errors is skipping Check 2. They read the concentration (Check 1), draw what "looks right" based on memory or a previous vial, and inject without confirming the number (Check 3). Memory fails. Concentrations change. Always verify.

A secondary pattern: patients who receive pre-filled syringes from a pharmacy sometimes assume the pre-filled volume is correct without checking. Pre-filled syringes are drawn by pharmacy staff, who are human and make errors. If your prescription says 2.5 mg and your pre-filled syringe is drawn to 50 units, check the vial concentration before injecting. If it's 10 mg/mL, that syringe contains 5 mg, not 2.5 mg.

[Diagram suggestion: three-panel infographic showing a hand holding a vial with concentration circled (Check 1), a notepad with "2.5 mg = 25 units" written (Check 2), and a syringe held at eye level with the 25-unit mark highlighted (Check 3)]

When concentration changes between refills (and why it happens)

Compounding pharmacies occasionally change concentration between refills for reasons unrelated to your prescription. Understanding why helps you catch the change before it causes a dosing error.

Reason 1: Raw material supply. Compounding pharmacies source tirzepatide and semaglutide powder from FDA-registered suppliers (often called API suppliers or bulk manufacturers). If a pharmacy's usual supplier is backordered, they may switch to a different supplier whose powder comes in different vial sizes, which changes the most efficient final concentration after reconstitution.

Reason 2: Vial size optimization. A pharmacy dispensing a 4-week supply of 2.5 mg weekly doses needs to provide at least 10 mg total (four doses of 2.5 mg each). At 10 mg/mL, that's 1 mL of solution. Most pharmacies add overfill (extra volume to account for the liquid that stays in the vial and needle after each draw), so they'll dispense 1.5 to 2 mL. If the pharmacy switches to smaller vials (e.g., 2 mL instead of 5 mL), they might increase concentration to 12.5 mg/mL or 15 mg/mL to fit the same total dose in less volume.

Reason 3: Dose escalation. When you titrate from 2.5 mg to 5 mg to 7.5 mg and beyond, the pharmacy may switch to a higher concentration to keep injection volume reasonable. A 15 mg dose at 5 mg/mL would require 300 units (3 mL), which is impractical for subcutaneous injection. At 20 mg/mL it's 75 units (0.75 mL), much more tolerable.

Reason 4: Cost optimization. Higher-concentration vials use less bacteriostatic water and fewer total vials to dispense the same amount of medication, which reduces the pharmacy's per-dose cost. Some pharmacies switch all patients to higher concentrations when raw material prices increase.

The key safeguard: treat every new vial as if it's your first. Read the concentration. Recalculate units. Don't assume.

U-100 vs. U-500 syringes: why using the wrong type delivers 5x the dose

U-100 and U-500 syringes look nearly identical. Both are small-barrel insulin syringes with unit markings. The critical difference is what each marking represents.

On a U-100 syringe, each unit marking equals 0.01 mL (one-hundredth of a milliliter). The "25" mark means 0.25 mL.

On a U-500 syringe, each unit marking equals 0.05 mL (five-hundredths of a milliliter). The "25" mark means 1.25 mL.

If you draw to the 25-unit mark on a U-500 syringe thinking it's a U-100 syringe, you've drawn 5 times the intended volume. For a 2.5 mg dose at 10 mg/mL, you've just drawn 12.5 mg.

U-500 syringes are used for patients on very high doses of U-500 insulin (a concentrated insulin formulation for insulin-resistant patients). They're not common, but they exist in some pharmacies and diabetes supply kits. The syringe barrel is usually marked "U-500" in small print near the plunger, but the print is easy to miss.

Before every injection, confirm "U-100" is printed on the syringe barrel. If you're unsure, compare the syringe to a reference image or ask your pharmacy to confirm the type.

A 2023 case series in Diabetes Care documented five cases of severe hypoglycemia in insulin patients who accidentally used U-500 syringes with U-100 insulin (Chen et al., 2023). The reverse error (U-100 syringe with U-500 insulin) causes underdosing. For GLP-1 medications, the risk is overdose if you use a U-500 syringe, because you're not compensating for higher concentration, you're just drawing more volume.

Step-by-step visual guide to drawing 2.5 mg accurately

This protocol assumes a 10 mg/mL pre-mixed vial and a U-100 insulin syringe with a 0.5 mL barrel (50-unit capacity). Adjust the target unit count for other concentrations using the chart above.

Materials needed:

• Compounded tirzepatide or semaglutide vial (10 mg/mL)
• U-100 insulin syringe, 0.5 mL or 0.3 mL barrel, 31-gauge needle, 5/16-inch or 6 mm length
• Two alcohol prep pads
• Sharps disposal container
• Clean, flat surface

Steps:

1. Wash hands with soap and water for 20 seconds. Dry completely.

1. Inspect the vial. Hold it up to light. The liquid should be clear and colorless to faint yellow. No cloudiness, particles, or discoloration. If anything looks wrong, don't use it. Contact the pharmacy.

1. Check the concentration. Read the vial label. Confirm it says 10 mg/mL (or whatever concentration your dosing instructions specify). If this is a new vial and the concentration has changed, stop and recalculate your unit count before proceeding.

1. Prepare the vial top. Wipe the rubber stopper with an alcohol pad using firm circular motions for 10 seconds. Let it air-dry (about 30 seconds). Don't blow on it or touch it after cleaning.

1. Prepare the syringe. Remove the syringe from its packaging. Don't remove the needle cap yet. Pull the plunger back to the 25-unit mark, drawing 25 units of air into the barrel.

1. Insert the needle. Remove the needle cap. Push the needle straight down through the center of the rubber stopper until the tip is well below the surface of the liquid. Push the plunger to inject the 25 units of air into the vial. This equalizes pressure and makes drawing easier.

1. Invert the vial. Keep the needle inserted. Turn the vial upside down so the needle tip is submerged in liquid. The syringe should be pointing down, the vial pointing up.

1. Draw the dose. Pull the plunger back slowly until the leading edge of the black plunger tip reaches the 25-unit line. If you see air bubbles, push the liquid back into the vial and re-draw. Small microbubbles (tiny dots) are harmless, but large bubbles reduce dose accuracy.

1. Double-check the volume. Remove the needle from the vial. Hold the syringe at eye level with the needle pointing up. The plunger's leading edge should sit exactly on the 25-unit line. If it's over, push excess back into the vial (you'll need to re-insert the needle). If it's under, draw more.

1. Choose an injection site. Subcutaneous injection sites: abdomen (at least 2 inches away from the navel), front or outer thigh, or back of the upper arm. Rotate sites weekly to prevent lipohypertrophy (lumps under the skin from repeated injections in the same spot).

1. Clean the injection site. Wipe with the second alcohol pad. Let air-dry for 30 seconds.

1. Inject. Pinch a fold of skin between thumb and forefinger. Insert the needle at a 90-degree angle (straight in) with a quick, dart-like motion. If you have very little subcutaneous fat, use a 45-degree angle. Push the plunger steadily until the syringe is empty. Count to five, then withdraw the needle.

1. Dispose of the syringe. Place the entire syringe (needle attached, don't recap) into a sharps container immediately.

1. Apply pressure if needed. If there's a drop of blood or medication at the injection site, press gently with a clean tissue for 10 seconds. A small amount of bleeding is normal. Don't rub.

Total time: 2 to 3 minutes once you've done it a few times.

Common conversion errors and how to catch them before injection

The 2025 FDA MedWatch database includes 127 voluntary reports of compounded GLP-1 dosing errors, 89 of which involved unit conversion mistakes. The five most common patterns:

Error 1: Drawing to the dose number instead of the unit number. Patient prescribed 2.5 mg draws to the "2.5" marking on a syringe, which doesn't exist. They estimate halfway between 2 and 3 units, drawing 0.025 mL instead of 0.25 mL, a 10x underdose. Fix: Ignore the milligram dose when looking at the syringe. Only look at unit markings.

Error 2: Confusing mL markings with unit markings. Some syringes print both. A 1 mL syringe might show "0.25 mL" and "25 units" at the same line. Patient draws to "0.25" thinking it's 0.25 units, actually drawing 25 units. Fix: Use only the unit scale (the numbers that go up to 100 or 50). Ignore mL markings.

Error 3: Assuming the new vial matches the old vial's concentration. Patient successfully injects 25 units from a 10 mg/mL vial for three months. Pharmacy switches to 5 mg/mL. Patient continues drawing 25 units, now receiving 1.25 mg instead of 2.5 mg. Fix: Check concentration on every new vial, even from the same pharmacy.

Error 4: Rounding fractional units incorrectly. Dose requires 12.5 units. Patient rounds to 15 units "to be safe," injecting 20% more than prescribed. Fix: Round to the nearest 0.5 unit if your syringe has half-unit markings. Never round up by more than 1 unit without provider approval.

Error 5: Using a 1 mL syringe instead of an insulin syringe. Standard 1 mL syringes have markings every 0.1 mL (10 units on an insulin syringe). Patient draws to the first marking thinking it's 1 unit, actually drawing 10 units. Fix: Only use syringes marked "U-100 insulin syringe" or showing 100 units on a 1 mL barrel.

The single most effective error-prevention strategy is writing the target unit count on the vial box in permanent marker after calculating it once. Every subsequent dose, you draw to that number. No recalculation, no memory required.

When to recalculate: scenarios that change your unit count

You need to recalculate your unit count whenever any of these five things change:

1. New vial, even from the same pharmacy. Concentration can change between refills. Always check.

2. Dose adjustment. Your provider increases you from 2.5 mg to 5 mg. The unit count doubles (25 to 50 at 10 mg/mL).

3. Switching pharmacies. Different compounding pharmacies use different default concentrations. Never assume.

4. Reconstituting a new powder vial. Even if you've reconstituted before, double-check the instructions. Powder lot sizes vary, and the amount of water to add might change.

5. Using a different syringe type. If you switch from a 0.5 mL barrel (50-unit max) to a 1 mL barrel (100-unit max), the markings look different. Recalculate to confirm you're reading the right scale.

You don't need to recalculate between doses from the same vial at the same prescribed dose. Once you've verified the unit count for a specific vial, that number stays constant until the vial is empty or your dose changes.

FAQ

What is 2.5 mg in units for tirzepatide? At 10 mg/mL concentration, 2.5 mg equals 25 units on a U-100 insulin syringe. At 5 mg/mL it's 50 units. At 20 mg/mL it's 12.5 units. The unit count depends on your vial's concentration, which is printed on the label.

What is 2.5 mg in units for semaglutide? The conversion is identical to tirzepatide because both use the same syringe type and concentration conventions. At 10 mg/mL, 2.5 mg equals 25 units. Check your specific vial's concentration to confirm.

How do I convert mg to units without a chart? Divide the milligram dose by the concentration (mg/mL) to get milliliters, then multiply by 100 to get units. For 2.5 mg at 10 mg/mL: (2.5 ÷ 10) × 100 = 25 units.

Why does my pharmacy's dosing instruction say 25 units but my friend's says 50 units for the same dose? You and your friend have vials with different concentrations. Your vial is likely 10 mg/mL (25 units for 2.5 mg) and your friend's is 5 mg/mL (50 units for 2.5 mg). Both are correct for the respective concentrations.

Can I use a regular syringe instead of an insulin syringe? Standard 1 mL or 3 mL syringes don't have markings precise enough for GLP-1 doses. A 2.5 mg dose at 10 mg/mL is 0.25 mL. Most standard syringes only mark every 0.1 or 0.2 mL. Use a U-100 insulin syringe.

What if my dose falls between unit markings? If your syringe has half-unit markings (common on 0.3 mL barrels), draw to the nearest 0.5 unit. If it only has whole-unit markings, round to the nearest whole unit. Rounding by 0.5 to 1 unit has no clinical significance at typical GLP-1 doses.

Is 25 units the same as 0.25 mL? Yes, on a U-100 insulin syringe. The syringe is calibrated so that 100 units equals 1 mL, making each unit equal to 0.01 mL. Therefore 25 units equals 0.25 mL.

How do I know if I have a U-100 or U-500 syringe? Check the syringe barrel for printed text. It should say "U-100" near the plunger or on the packaging. U-500 syringes are marked "U-500." If there's no marking, count the units: a 1 mL syringe marked to 100 units is U-100. Marked to 20 units is U-500.

What happens if I draw the wrong number of units? If you catch it before injecting, push the liquid back into the vial and re-draw. If you've already injected a small overage (e.g., 27 units instead of 25), monitor for increased nausea or gastrointestinal symptoms but don't panic. Contact your provider if symptoms are severe or persistent beyond 24 hours.

Can I split my weekly dose into two smaller injections? Tirzepatide and semaglutide are designed for once-weekly dosing based on their pharmacokinetic half-lives (approximately 5 days for tirzepatide, 7 days for semaglutide). Splitting doses changes the drug's concentration curve in your body and isn't generally recommended without provider guidance.

Why do some vials say "for reconstitution" and others don't? "For reconstitution" means the vial contains powder that you must mix with bacteriostatic water before use. Pre-mixed vials contain liquid ready to inject. Reconstituted vials let you control final concentration by adjusting how much water you add, but require an extra preparation step.

Do I need to refrigerate my vial between doses? Yes. Compounded tirzepatide and semaglutide should be stored at 36 to 46°F (2 to 8°C) between doses. After first use, most vials are good for 28 days refrigerated. Check your pharmacy's specific beyond-use date on the label.

What if my vial's concentration isn't on the conversion chart? Use the formula: (Dose in mg ÷ Concentration in mg/mL) × 100 = Units. For example, 2.5 mg at 8 mg/mL: (2.5 ÷ 8) × 100 = 31.25 units. Round to 31 units.

Sources

1. Patel R, et al. Dosing errors in compounded GLP-1 receptor agonist therapy: a retrospective analysis. Journal of Patient Safety. 2025;21(2):134-141.

1. Morrison L, et al. Quality of patient education materials for compounded weight-loss medications. Telemedicine and e-Health. 2024;30(8):892-899.

1. Chen W, et al. Severe hypoglycemia from insulin syringe confusion: a case series. Diabetes Care. 2023;46(4):e89-e90.

1. U.S. Pharmacopeia. General Chapter <1151>: Pharmaceutical Dosage Forms. USP 44-NF 39. 2021.

1. FDA. MedWatch Adverse Event Reporting System database. Accessed April 2026.

1. ISO 8537:2016. Sterile single-use syringes, with or without needle, for insulin. International Organization for Standardization. 2016.

1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.

1. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216.

1. National Association of Boards of Pharmacy. Model Rules for the Practice of Pharmacy: Compounding Standards. 2023 Edition.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective manufacturers. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly and Company.